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ABSTRACT. Six new complexes, [Mn(BrU)2(H2O)2]4H2O (1), [Cd(BrU)2]2H2O (2), 
[Cu(BrU)2(H2O)2]2H2O (3), [Co(BrU)2(H2O)2]4H2O (4), [Ni(BrU)2(H2O)2]4H2O (5) and 
[Ag(BrU)(BrUH)]2(H2O) (6)  were prepared by the reaction of 5-bromoouracil with MnCl2·4H2O, 
CdCl2·2.5H2O, CuSO4·5H2O, (CH3COO)2Co·4H2O, (CH3COO)2Ni·4H2O and AgNO3 respectively. The 
complexes were characterized by melting point, elemental microanalyses, IR and 1H NMR spectroscopy. The 
obtained data indicated that the ligand interacted with the metal ions in its mononegatively charged enol form in a 
bidentate fashion. Thermogravimetric analyses (TGA and DTG) were also carried out. The data obtained agreed 
well the proposed structures and showed that the complexes were finally decomposed to the corresponding metal 
or metal oxide. The ligand and its metal-ion complexes were tested for their antimicrobial activities against four 
bacterial strains (B. subtillis, S. aureus, E. coli and P. aeruginosa) by the agar-well diffusion technique using 
DMSO as a solvent. The obtained data showed that the complexes were more potent antimicrobial agents than the 
parent ligand. 
  




Uracil is a naturally occurring nucleic acid [1] and is the most important 
pyrimidine base that represents remarkable roles in the structures and functions of enzymes and 
drugs [2]. In recent years, uracil and its derivatives and complexes have been used in the 
synthesis of antibacterial, antiviral and anti-tumour agents [3–5]. Intensive investigations have 
shed light on the natures of the interactions between metal ions and nucleic acid bases, including 
their abilities to form complexes [2] which have wide-ranging biological activities, such as 
antimalarial, antitumoural, antibacterial, and antiviral activities [6, 7]. 
5-Bromouracil (BrUH), (5-bromopyrimidine-2,4(1H,3H)-dione) (Scheme 1), is a 
halogenated derivative of uracil which has the ability to terminate DNA replication in viruses 
and other cell culture systems [8–11]. This termination of DNA replication occurs via the 
replacement of a thymine base in the genetic code with 5-bromouracil, resulting in an unusual 
code that stops the replication process [12, 13]. On the other hand, the thymine replacement by 
5-bromouracil in the DNA genetic sequence has a significant influence on cancer therapy, 
leading to higher sensitivity to ionizing radiation [14, 15] without influencing  the un-irradiated 
cells. Moreover, 5-bromouracil has a great influence on the growth of viruses, bacteria and other 
microorganisms [8–11]. Heterocyclic molecules have tautomeric forms at equilibrium in 
solutions, where hydrogen atoms can move to various locations within the molecules. In this 
respect, 5-bromouracil isomers exist in enol and keto tautomeric forms [13], Scheme 2. 
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where X = H (uracil)     X = Br (5-bromouracil) 
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Scheme 2. Tautomeric forms of bromouracil. 
 
At alkaline pH values, the hydrogen atom bonded to the N(3) atom in the keto form of 5-
bromouracil is removed, indicating that the N(3) hydrogen atom is acidic (pKa = 8); however, 
the N(1) atom is basic [13, 16]. 5-Bromouracil is a nucleotide base that can bind to metals or 
bind to tissues via metals [17–19]. Additionally, its complexes or compounds have been 
identified as biologically active materials acting as antibacterial and anti-tumour agents [18, 20]. 
In this article, the preparation, characterization and biological activities of Mn(II), Cd(II), 
Co(II), Ni(II), Cu(II) and Ag(I) complexes with 5-bromouracil has been described. The 
determination of the binding sites of 5-bromouracil with these metal ions can give additional 
value by correlating the coordination modes of 5-bromouracil with its biological activity. The 
obtained complexes were characterized by elemental analysis, infrared (IR) spectroscopy, 1H 
nuclear magnetic resonance (NMR) spectroscopy, melting point, conductivity measurements as 








5-Bromouracil, KOH and metal salts, i.e. MnCl2·4H2O, CdCl2·2.5H2O, CuSO4·5H2O, 
Co(CH3COO)2·4H2O, Ni(CH3COO)2·4H2O and AgNO3, used in this study were purchased in 




Elemental analysis for C, H and N was carried out in the Microanalysis Department of Cairo 
University, Egypt, using a VARIO EL III elemental analyzer. Infrared measurements (KBr-
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Analytical Department, Al-Azhar University, Cairo, Egypt). 1H NMR measurements were 
performed using DMSO as a solvent on a Bruker spectrometer (Zagazig University, NMR 
Department, Zagazig, Egypt). TGA was carried out at a heating rate of 10 oC using a Universal 
TGA Q500 instrument (Science & Technology Center of Excellence, Cairo, Egypt). Molar 
conductivities of the complex solutions (110-3 M) in dimethylformamide (DMF) were 
measured at room temperature using a Jenway 4510 conductivity meter. The heavy metals 
which include manganese (Mn), cadmium (Cd), copper (Cu), cobalt (Co), nickel (Ni), and silver 
(Ag) are detected by ICP Spectrophotometer Thermo Jarrel Ash model POEMS 3, using 1000 
mg/L (Merck) stock solution for standard preparations. 
 
Preparation of the ligand solution 
 
5-Bromouracil (764.0 mg, 4.0 mmol) was suspended in 30.0 mL of distilled H2O, (pH = 4.2), 
and a KOH solution (1.0 M) was added dropwise until reaching pH to 10 or and complete 
dissolution of the ligand. 
 
Syntheses of the metal complexes  
 
To the prepared ligand solution, 50.0 mL of an aqueous solution (2.0 mmol) of the 
corresponding metal salt, i.e. MnCl2·4H2O (395.0 mg), CdCl2·2.5H2O (456.0 mg), CuSO4·5H2O 
(499.0 mg), Co(CH3COO)2·4H2O (498.0 mg), Ni(CH3COO)2·4H2O (497.0 mg) or AgNO3 
(393.7 mg), was added. The reaction mixture was stirred for around 5 h at 65 °C. The obtained 
precipitate was filtered, washed several times with a few drops of distilled water, and then dried 
in an oven (50 °C) for 2 h and then in a silica gel desiccator.  
 
[Mn(BrU)2(H2O)2]4H2O (1). Yield: (50.10%). M.P.: 340 °C. Colour: yellowish brown. 
Analysis found% (calculated % for C8H16Br2MnN4O10, 542.98): C, 18.05 (17.70); H, 2.96 
(2.97); Mn 10.19 (10.12); N, 10.74 (10.32).  
 
[Cd(BrU)2]2H2O (2). Yield: (39.60%). M.P.: >350 °C. Colour: white. Analysis found% 
(calculated % for C8H8Br2CdN4O6, 528.39): C, 18.24 (18.18); H, 1.99 (1.53); Cd, 21.50 (21.27), 
N, 10.34 (10.60).  
 
[Cu(BrU)2(H2O)2]2H2O (3). Yield: (65.80%). M.P.: 295 °C. Colour: green. Analysis found% 
(calculated % for C8H12Br2CuN4O8, 515.56): C, 18.23 (18.64); H, 2.52 (2.35); Cu, 12.48 
(12.33); N, 10.54 (10.87). 
 
[Co(BrU)2(H2O)2]4H2O (4). Yield: (66.90%). M.P: 315 °C. Colour: red. Analysis found% 
(Calculated% for C8H16Br2CoN4O10, 546.97): C, 17.50 (17.57); H, 3.33 (2.95); Co, 10.89 
(10.77); N 10.43 (10.24). 
 
[Ni(BrU)2(H2O)2]4H2O (5). Yield: (85.90%). M.P.: 318 °C. Colour: faint green. Analysis 
found% (calculated % for C8H16Br2N4NiO10, 546.73): C, 17.60 (17.57); H, 3.03 (2.95); Ni, 
10.81 (10.74); N, 10.34 (10.25). 
 
[Ag(BrU)(BrUH)]2H2O (6). Yield: (88.40%). M.P.: 278 °C. Colour: white silvery. 
Analysis found% (calculated % for C8H9AgBr2N4O6, 524.86): C, 17.98 (18.31); H, 1.79 (1.73); 
Ag, 21.05 (20.55); N, 10.36 (10.67). 
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The in vitro antibacterial effects of the compounds were tested against four bacterial strains, i.e. 
E. coli and P. aeruginosa (Gram-negative bacteria) and B. subtillis and S. aureus (Gram-
positive bacteria), by an agar well diffusion method using nutrient agar medium [21-23]. All 
bacteria were inoculated into nutrient broth and incubated for 24 h (1.0 mL of inoculant was 
added to 50 mL of agar media (50 ºC) and mixed). The agar was poured into 120 mm petri 
dishes and allowed to cool to room temperature. In the agar well diffusion method, the dilution 
plate method was used to enumerate microorganisms for 24 h [24, 25]. Using a sterilized cork 
borer (7 mm diameter), wells were dug into the culture plates. The compounds dissolved in 
DMSO (0.1 mL, 250 μmol/mL) were added to these wells. The petri dishes were left at 5 ºC for 
2 h, and then, the plates were incubated at 35 ºC for bacterial growth (24 h). At the end of the 
period, the inhibition zones formed on the medium were evaluated in millimetres (mm). DMSO 
(0.1 mL) was used as a control under similar conditions. The inhibition zones based on the zone 
size around the discs were measured and calculated as means of triplicates and are reported as 
average values of three experiments.  
RESULTS AND DISCUSSION 
 
Free ligand and complexes 
 
All the prepared complexes are insoluble in many organic solvents (methanol, ethanol, 
acetonitrile, chloroform, carbon tetrachloride) and water. Complexes 1, 4 and 6 are soluble in 
DMF, while the other complexes 2, 3 and 5 are slightly or sparingly soluble in DMF. These 
complexes were characterized by IR, 1H NMR spectroscopy, melting point measurements, 




The conductivity values measured at 25 C in DMF for 10−3 M solutions of the free ligand and 
its complexes are very small, and their values lie in the range of 3.17– 8.2 µs·cm−1, indicating 




The infrared spectrum of the free ligand (Table 1) shows a strong broad band at 1677 cm−1 
characteristic of (C(4)=O) and a shoulder at 1617 cm−1 corresponding to (C(2)=O), which are 
practically overlapped. Two weak/medium bands are observed at 3360 and 3168 cm−1, which 
may be assigned to (N(3)−H) and (N(1)−H) stretching vibrations, respectively. 
  The assignments of the well-defined bands in the infrared spectra of the complexes are 
summarized in Table 1. The υ(C=O) of the free ligand is observed at 1677 cm−1, while the 
corresponding vibrations in the metal complexes are observed in the range of 1611−1640 cm−1. 
A shift of 30-50 cm−1 to lower frequencies is observed for the carbonyl band after coordination 
with the metal ions, clearly indicating the coordination of the carbonyl group to the metal ions. 
The disappearance of the absorption band at 3360 cm−1 (N(3)−H in the free ligand spectrum) in 
the complex spectra indicates that the N(3) atom is bound to the metal ions. The complex 
spectra show an absorption band in the range of 1590-1525 cm−1. This band is not observed in 
the spectrum of the free ligand and may be attributed to the stretching motion associated with 
the C=N bond resulting from the transformation of the ligand from the keto form to the enol 
form upon complexation. The observation of such a band in the complex spectra support the 
assumption that 5-bromouracil is coordinated with the metal ions as a mononegative bidentate 
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ligand through one oxygen atom of the carbonyl group and the N(3) atom. This coordination 
mode is also supported by the observation of two weak bands in the ranges of 609−563 and 
550−510 cm−1, which are attributed to M−N and M−O stretching modes, respectively. These 
two bands are not observed in the spectrum of the free ligand [27-31]. 
According to the forgoing discussion and based on the proposed molecular formulas, the 
probable structures of the Mn(II), Co(II), Ni(II), and Co(II) complexes are in octahedral 
geometries. On other hand, the structures for the Cd(II) and Ag(I) complexes are more likely in 











































Scheme 3. Suggested structures for the 5-bromouracil-metal ion complexes. 
 
Table 1. Selected IR frequencies (cm−1) and tentative assignments for 5-bromouracil (as a free ligand) and 
its metal complexes (1-6). 
 
(BrUH) 1 2 3 4 5 6 Assignments 
3467 w,br 3448 vs 3415 s,br 3409 vs,br  3433 vs,br 3440.3 vs,br 3419 w,br υ(O–H), H2O 
3360  sh  ------- ------- ------- ------- ------- ------- υ(N3–H) 
3168 m 3187 m 3137 w,br   3202 w  3118 m 3117 s 3150 w υ(N1–H) 
3060  m 3125 m 3020 w,br   3077 vw  3029 vw 3029 vw 3048 vw υ(C–H), aromatic 
1677 vs 1612 vs   1641 s   1643 vs  1611 s 1618 vs 1640 vs υ(C═O) 
------- 1590 sh   1572 w   1578 sh  1576 s 1573 vs 1525 vs υ(C═N) 
1427  s   1392 s   1454 s   1470 m  1389 vs 1394 vs 1404 m υ(C–C); (N1–H) 
1224 m 1271 m   1274 m   1281 m  1272 vs 1278 m 1273 m υ(C–N); (CO) 
1054 w 1010 m   1026 s   1063 m  1080 m 1082 w 1068 w υ(C–Br) 
------- 583 w    562 sh     609 sh    586 m   592 w  576 m υ(M–N) 
------- 550 sh    509 sh     536 w    520 w   517 vw  477 w υ(M–O) 
Where, sh = shoulder, s = strong, m = medium, w = weak, br = broad, v = very. 
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 1H NMR spectra  
 
The 1H NMR spectral data of free 5-bromouracil and its Cd(II) and Ag(I) complexes in DMSO 
are summarized in Table 2. The spectra reveal a characteristic signal for the aromatic proton in 
its expected region of 7.00−8.00 ppm. The N(1)H signal is located at 11.13 ppm in the 
spectrum of the free ligand, while the corresponding signals in the spectra of the Cd(II) and 
Ag(I) complexes are observed at 10.90 and 10.85 ppm, respectively. The N(3)−H signal in the 
free ligand spectrum (11.51 ppm) is absent in the spectra of the complexes, which is consistent 
with the forgoing suggestion that 5-bromouracil reacted with the metal ions through its enol 
form. The Ag(I) complex exhibits a signal at 10.51 ppm, and such a signal is neither present in 
the spectrum of the free ligand nor in the spectra of the other complexes. This signal may be 
attributed to the (OH) proton associated with one of the two ligands coordinated with the Ag(І) 
ion. Accordingly, one of the two ligands bonded to the Ag(І) ion is a neutral molecule in the 
enol form, while the other is negatively charged, as shown in Scheme ІІІ. The 1H NMR 
spectrum of the free ligand confirms the results obtained from the IR spectrum. The obtained 
data suggests that 5-bromouracil is in the keto form. Dissolving the base with additional KOH 
converts the keto form to the enol form, forming a soluble salt with the deprotonation of N(3)−H 
as the pH is raised to 10 [37, 38].  
 
Table 2. 1H NMR data in ppm and assignments for 5-bromouracil as a free ligand and its Cd(II) and Ag(I) 
complexes. 
 
Compound C6−H N1−H N3−H OH H2O 
Free ligand (Br-UH) 7.88 (1H) 11.13 11.51 (1H) ----- 3.35 
[Cd(BrU)2]4H2O (2) 7.85 (1H) 10.90 ----- ----- 3.34 




To confirm the proposed structures of the complexes, thermogravimetric analyses (TGA) were 
performed. The thermal data for all complexes are summarized in Table 3. The free ligand 
completely decomposes in one step at approximately 320 °C, as shown in Figure 1, indicating 
its pure organic structure. 
  The decomposition reactions of [Mn(BrU)2(H2O)2]4H2O, [Cd(BrU)2]2H2O, 
[Cu(BrU)2(H2O)2]2H2O, [Co(BrU)2(H2O)2]4H2O, [Ni(BrU)2(H2O)2]4H2O and 
[Ag(BrU)(BrUH)]2H2O occur in four, five or six steps from 120 °C to 1000 °C, as shown 
in Figure 1. In these complexes, the first decomposition step proceeds at a temperature between 
120 °C and 210 °C with a weight loss ranging from of 6.30−13.50%, associated with the loss of 
the outer-sphere (uncoordinated) water content. The calculated ratio of the outer-sphere water 
content in the suggested forms is between 6.82% and 13.27%, in good agreement with the 
observed values (Table 3). 
The second thermal decomposition step for complexes 1, 3, 4, and 5 displayed weight loss in 
the range of 6.71−7.50% at a temperature range of 240−275 °C, which may be attributed to the 
loss of coordinated water. This result agrees with the calculated coordinated water values of 
6.59–6.99% in the suggested formulas of these complexes. The TGA thermograms of 
complexes 2 and 6 shows no weight loss in this temperature range, indicating the absence of any 
coordinated water, which is consistent with the suggested formulas of both complexes. 
The loss of organic content associated with the ligands occurs in the next two to six 
decomposition steps at maximum temperatures between 283 °C and 925 °C. The weight loss 
associated with these decomposition steps (65.75−78.49%) is in agreement with the calculated 
values  (66.54−72.59%).  The total weight loss throughout the decomposition process lies in the  
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Table 3. The maximum temperature values for the decomposition along with the species lost in each step of 
the decomposition reactions of 5-bromouracil and its complexes. 
 
Complex Decomposition Tmax (°C) Lost species 
% of weight loss 
Found Calcd 







1st step 138 4H2O 13.32 13.27 
2nd step 280 2H2O   6.71   6.63 
3rd step 331 --- --- --- 
4th step 510 --- --- --- 
5th step 707 C8H4Br2N4O3 68.07 67.03 
Total loss ---- C8H16Br2N4O9 88.10 86.93 







1st step 210 2H2O 6.30 6.82 
2nd step 407 ---- ---- ----- 
3rd step 539 --- ---- --- 
4th step 724 --- ---- --- 
5th step 925 C8H4Br2N4O3 71.20 68.88 
Total loss ---- C8H8Br2N4O5 77.50 75.70 







1st step 120 2H2O 6.50 6.99 
2nd step 240 2H2O     7.00 6.99 
3rd step 283 --- --- --- 
4th step 355 --- --- --- 
5th step 627 C8H4Br2N4O4 75.00 70.59 
Total loss ---- C8H12Br2N4O7 87.50 84.57 







1st step 167 4H2O 13.50 13.17 
2nd step 269 2H2O   7.50   6.59 
3rd step 334 ---- ---- ---- 
4th step 624 C8H4Br2N4O3 65.75 66.54 
Total loss ---- C8H16Br2N4O9 86.75 86.30 





1st step 170 4H2O 13.50 13.18 
2nd step 275 2H2O   6.90   6.59 
3rd step 290 ---- ---- ---- 
4th step 393 ---- ---- ---- 
5th step 564 ---- ---- ---- 
6th step 762 C8H4Br2N4O3 67.10 66.57 
Total loss ------ C8H16Br2N4O9 87.50 86.34 








1st step 160 2H2O 6.37 6.86 
2nd step 299 ---- ---- ---- 
3rd step 393 ---- ---- ---- 
4th step 625 ---- ---- ---- 
5th step 819 C8H5Br2N4O4 78.49 72.59 
Total loss ---- C8H9Br2N4O6 82.49 79.45 
Residue ---- Ag 18.94 20.55 
 
range of 77.50−88.10%, which in good agreement with the theoretical values for the suggested 
structures (75.70−86.94%). The decomposition processes for the Mn(II), Cd(II), Cu(II), Co(II) 
and Ni(II) complexes left residue of the corresponding metal(II) oxides. The TGA thermograms 
show that the ratios of these metal oxide residues are in the range of 11.90−22.50% of the total 
weight, where the theoretical ratio calculated for the metal oxides resulting from the suggested 
262
structures is between 13.04−24.30%. The decomposition process for the Ag(I) complex left 
residue of silver metal (Ag), corresponding to 18.94% of the total weight of complex, in good 
agreement with the calculated ratio of silver metal in the suggested Ag(I) complex (20.55%) 
[39]. 
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The in vitro antibacterial activities of the compounds under investigation were tested against 
four bacterial strains, i.e. two Gram
negative bacteria (E. coli and P. aeru
Complexes 1, 3 and 4 showed good activities against the Gram
subtillis and S. aureus and moderate activity against Gram
P. aeruginosa. Complex 5 
Complexes 2 and 6 showed excellent activities compared to the positive control against Gram
positive B. subtillis and S. aureus
aeruginosa. The remarkable activities of the complexes may
geometries of the molecules and the type of metal ion [40]
 
Table 4. Antibacterial activities for the 5
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showed good activities against the selected bacterial strains. 
 and moderate activity against Gram-negative E. coli and 
 be due to structural changes 
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In our study, we have prepared different types of 5-bromouracilmetal ion complexes by the 
reaction of 5-bromoouracil with MnCl2·4H2O, CdCl2·2.5H2O, CuSO4·5H2O, 
(CH3COO)2Co·4H2O, (CH3COO)2Ni·4H2O and AgNO3, respectively. The complexes were 
structurally characterized by melting point, elemental analyses measurements, electrical 
conductivity, IR and 1H NMR spectroscopy. The obtained data indicated that the ligand 
interacted with the metal ions in its mononegatively charged enol form in a bidentate fashion 
and the complexes have a 1:2 metal-to-ligand stoichiometry. Thermogravimetric analyses (TGA 
and DTG) were also achieved. The data obtained agreed with the proposed structures and 
showed that the complexes were finally decomposed to the corresponding metal oxide or metal. 
The prepared 5-bromouracilM2+ complexes were screened for their antimicrobial activities by 
an agar-well diffusion technique using DMSO as a solvent and showed that the complexes were 
potent antimicrobial.  
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